Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD

Last | 3:39 PM EDT

123.20

+0.97 (+0.79%)

Volume

3,154,287

52 week range

115.61 - 403.30

Open123.58
Day High126.29
Day Low121.82
Prev Close122.23
52 Week High403.30
52 Week High Date09/28/21
52 Week Low115.61
52 Week Low Date06/13/22

Key Stats

Market Cap48.196B
Shares Out391.20M
10 Day Average Volume5.87M
Dividend-
Dividend Yield-
Beta1.69
YTD % Change-51.56

KEY STATS

Open123.58
Day High126.29
Day Low121.82
Prev Close122.23
52 Week High403.30
52 Week High Date09/28/21
52 Week Low115.61
52 Week Low Date06/13/22
Market Cap48.196B
Shares Out391.20M
10 Day Average Volume5.87M
Dividend-
Dividend Yield-
Beta1.69
YTD % Change-51.56

RATIOS/PROFITABILITY

EPS (TTM)32.80
P/E (TTM)3.76
Fwd P/E (NTM)7.87
EBITDA (TTM)15.945B
ROE (TTM)113.86%
Revenue (TTM)22.995B
Gross Margin (TTM)82.29%
Net Margin (TTM)61.12%
Debt To Equity (MRQ)4.24%

EVENTS

Earnings Date11/02/2022(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

Covid vaccination linked to small increase in menstrual cycle length: NIH study5 Hours AgoCNBC.com
Stocks making the biggest moves midday: Hertz, Keurig Dr. Pepper and more September 27, 2022CNBC.com
Pfizer or Moderna: Which new omicron-specific Covid booster should you get?September 27, 2022CNBC.com
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11September 26, 2022CNBC.com
New minimum tax could hit Berkshire Hathaway and Amazon hardest, study showsSeptember 25, 2022CNBC.com

Content From Our Affiliates

Moderna says requests for EUAs for Omicron booster for kids submitted to FDASeptember 23, 2022TipRanks
What You Missed On Wall Street This MorningSeptember 23, 2022TipRanks
Moderna COVID-19 booster shortage causes canceled appointments, WSJ reportsSeptember 23, 2022TipRanks
Moderna ‘eager’ to work with China on vaccine supply, Reuters saysSeptember 21, 2022TipRanks
What You Missed On Wall Street On TuesdaySeptember 20, 2022TipRanks

Profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

James Mock

Chief Financial Officer

Juan Andres

Chief Technical Operations and Quality Officer

Address

200 Technology Sq

Cambridge, MA

02139-3578

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BNTX BioNTech SE	134.25	+3.96	+3.04%
REGN Regeneron Pharmaceuticals Inc	709.00	+13.99	+2.01%
BIIB Biogen Inc	275.82	+78.03	+39.45%
ILMN Illumina Inc	200.69	+13.85	+7.41%
ALNY Alnylam Pharmaceuticals Inc	210.69	+8.08	+3.99%